OpenVSafe by OpenVAERS
Search V-safe

EEB-20039-62848

4 vaccinations 8 coded responses 31 check-ins 8 free-text entries 5 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
372 / TN
Registered
2020-12-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2209408 (opens in a new window) high 9 / 11 — 2 of 13 VAERS symptoms same dose (4) TN matches 2022-02-12 / 2022-03-01 / 2022-03-31
received the same day as the last call
case 404484

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-30
    Registered in v-safe
  2. 2020-12-30
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-30
    Survey response — day 0, dose 1
    MedDRA: Flushing, Hypertension — Feeling: Good · Site: Redness · Headache
    Free text: Flushing of face, high blood pressure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  5. 2021-01-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Diarrhea, Abdominal pain
    Adult check-in
  8. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Good · None · Be unable to work
    Adult check-in
  9. 2021-01-06
    Report sent to call center — day 7, dose 1
    Be unable to work
    1 call case(s)
  10. 2021-01-15
    Survey response — day 14, dose 1
    MedDRA: Adrenal insufficiency, Asthenia, Balance disorder, Decreased appetite, Dizziness, Fall, Fatigue, Tunnel vision — Feeling: Fair · Be unable to work
    Free text: Adrenal insufficiency episode with no known infection or illness. Dizziness, tunnel vision, fall on ground, loss of balance, no appetite, weakness and severe fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-15
    Report sent to call center — day 14, dose 1
    Be unable to work
    1 call case(s)
  12. 2021-01-20
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-01-21
    Dose 2 — Pfizer-BioNTech
  14. 2021-02-10
    Survey response — day 14, dose 2
    MedDRA: Diarrhoea — Feeling: Good
    Free text: Diarrhea is worse
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-02-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-25
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-03-04
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-23
    Survey response — 3 months, dose 2
    MedDRA: Dyspnoea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Worsening difficulty breathing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-07-23
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-09-10
    Dose 3 — Pfizer-BioNTech
  22. 2021-09-29
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  23. 2021-10-02
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  24. 2021-10-08
    Survey response — day 28, dose 3
    MedDRA: Anxiety, Pre-existing disease — Feeling: Fair · Be unable to work or attend school
    Free text: Worsening anxiety
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-17
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  26. 2021-10-22
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  27. 2021-12-10
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  28. 2022-02-12
    Dose 4 — Pfizer-BioNTech
  29. 2022-02-12
    Health check-in — day 0, dose 4
    Feeling: Fair · Site: Pain · Diarrhea
    Adult check-in
  30. 2022-02-13
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  31. 2022-02-14
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  32. 2022-02-26
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-03-08
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-03-13
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  35. 2022-03-21
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-03-26
    Survey response — day 42, dose 4
    MedDRA: Raynaud's phenomenon — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Raynaud's phenomenon
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-03-26
    Report sent to call center — day 42, dose 4
    Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  38. 2022-03-28
  39. 2022-03-31
    Call successful
    Completed over the phone
  40. 2022-05-15
    Survey response — 3 months, dose 4
    MedDRA: Erythema, Flushing, Peripheral swelling, Raynaud's phenomenon — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Hands are red and swollen most of time, Raynaud phenomenon (new after booster) is worse, areas of arms and upper arms are red and stay flushed
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-05-15
    Report sent to call center — 3 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  42. 2022-05-16
  43. 2022-08-13
    Survey response — 6 months, dose 4
    MedDRA: Erythromelalgia — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Erythromelalgia
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-08-13
    Report sent to call center — 6 months, dose 4
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  45. 2022-08-15
  46. 2022-08-15

Vaccinations

DoseDateManufacturerCo-administered
12020-12-30Pfizer-BioNTech
22021-01-21Pfizer-BioNTech
32021-09-10Pfizer-BioNTech No
42022-02-12Pfizer-BioNTech No

Call center

5 call center cases

1 successful · 2 unsuccessful · 2 priority 2/3 (triaged and no follow up)

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 1 — day 0, dose 1

2020-12-30

Systemic reaction (other): Flushing of face, high blood pressure

Release 2 — day 14, dose 1

2021-01-15

Symptoms: Adrenal insufficiency episode with no known infection or illness. Dizziness, tunnel vision, fall on ground, loss of balance, no appetite, weakness and severe fatigue

Release 4 — day 14, dose 2

2021-02-10

Symptoms: Diarrhea is worse

Release 7 — 3 months, dose 2

2021-04-23

Symptoms: Worsening difficulty breathing

Release 10 — day 28, dose 3

2021-10-08

Symptoms: Worsening anxiety

Release 11 — day 42, dose 4

2022-03-26

Symptoms: Raynaud's phenomenon

Release 11 — 3 months, dose 4

2022-05-15

Symptoms: Hands are red and swollen most of time, Raynaud phenomenon (new after booster) is worse, areas of arms and upper arms are red and stay flushed

Release 12 — 6 months, dose 4

2022-08-13

Symptoms: Erythromelalgia

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdrenal insufficiency ✓ ✓ ✓
SDAnxiety · · ✓
SDAsthenia ✓ ✓ ✓
SDBalance disorder ✓ ✓ ✓
SDDecreased appetite ✓ ✓ ✓
SDDiarrhoea ✓ ✓ ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDErythema · · ✓
SDErythromelalgia · · ✓
SDFall ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFlushing · · ✓
SDPeripheral swelling · · ✓
SDPre-existing disease · · ✓
SDRaynaud's phenomenon · · ✓
SDTunnel vision ✓ ✓ ✓
SROFlushing ✓ ✓ ✓
SROHypertension ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release